INVESTOR REMINDER: Berger Montague Notifies Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Investors of a Class Action Lawsuit and Deadline
(NASDAQ:REGN), PHILADELPHIA, Jan. 21, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit has been filed against REGENERON PHARMACEUTICALS, INC. (“Regeneron” or the “Company”) (NASDAQ: REGN). The lawsuit has been filed on behalf of purchasers of Regeneron securities between November 2, 2023 and October 30, 2024, inclusive (the “Class Period”). CLICK HERE TO LEARN MORE […]